Skip to Main Content

Inari Medical, Inc. (NASDAQ: NARI) Securities Fraud Class Action

CompanyInari Medical, Inc.
CourtUnited States District Court for the Southern District of New York
Case Number24-cv-03686
JudgeHonorable Gregory H. Woods
Class PeriodMarch 10, 2021 through February 28, 2024
Security TypeSecurities

Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Inari Medical, Inc. (“Inari Medical”) (NASDAQ: NARI) securities between March 10, 2021 and February 28, 2024, inclusive (the “Class Period”).

The complaint alleges that, throughout the Class Period, Defendants consistently touted Inari Medical’s “record revenue,” purportedly driven by “the strength in our core VTE business” but failed to disclose that a significant portion of its expenses were used to compensate medical professionals improperly for using Inari Medical’s products. In truth, while Defendants were speaking positively about the Company’s growth prospects, Inari Medical had been engaging in illegal business practices. Specifically, Inari Medical had been unlawfully compensating health care professionals in violation of the federal Anti-Kickback Statute and Civil False Claims Act while also misleading investors regarding business expenses in order to conceal their illicit conduct. 

Current Status of Case:
On September 4, 2025, Defendants filed a Motion to Dismiss the Amended Complaint. The Motion has been fully briefed and is pending decision before the Court. This action is ongoing. 

If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent. 

Complete this form with your transactions in Li Auto Inc. securities between March 10, 2021 and February 28, 2024.

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Inari Medical, Inc. prior to the Class Period?
Are you a current or former employee of Inari Medical, Inc. ?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter.
Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By submitting this form, you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email